Give the gift of LIFE! Support the Population Research Institute!


Topics: Andrew von Eschenbach

President’s Page: The Bad News from November

The bad news began right after the November elections. And on December 7, the Senate voted to confirm the nomination of Andrew von Eschenbach as Commissioner of the federal Food and Drug Administration (FDA). As Acting Commissioner, Esehenbach approved the over-the-counter sale of the abortion-causing “morning-after pill.” and did nothing to protect women from RU-486, despite the at least eight deaths and hundreds of injuries resulting from its use. Two pro-life senators, Jim DeMint (R.-SC.) …

Read more.

FDA Prepares Sell-Out on MAP

11 Aug 2006     Vol. 8 / No. 31 FDA Prepares Sell-Out on MAP After resisting for years feminists determined to make high-dosage steroids available to women and girls without a prescription, it seems that the Bush Administration is about to cave in to political pressure and make the morning-after pill (MAP) accessible over the counter to those over 18.  Not only will this result in the deaths of more unborn children since MAP often acts after …

Read more.

Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.